Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.
about
Strategies for early detection of resectable pancreatic cancerMolecular detection of pancreatic neoplasia: Current status and future promiseTissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challengesApplications of targeted proteomics in systems biology and translational medicineAdvances in targeted proteomics and applications to biomedical researchCombining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkersPeptideManager: a peptide selection tool for targeted proteomic studies involving mixed samples from different species.Bacterial protein signals are associated with Crohn's disease.Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics.Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.Proteomics analysis of bodily fluids in pancreatic cancerIdentification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based ProteomicsExtensive quantitative remodeling of the proteome between normal colon tissue and adenocarcinoma.Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.Both targeted mass spectrometry and flow sorting analysis methods detected the decreased serum apolipoprotein E level in Alzheimer's disease patientsQuantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometryMetabolism addiction in pancreatic cancer.Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Plasma Gelsolin Induced Glomerular Fibrosis via the TGF-β1/Smads Signal Transduction Pathway in IgA Nephropathy.MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Biomarkers for early diagnosis of pancreatic cancer.Premetastatic niche formation in the liver: emerging mechanisms and mouse models.Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Clinical applications of MS-based protein quantification.Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential.Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis.Assessment of the Therapeutic Potential of Persimmon Leaf Extract on Prediabetic Subjects.Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography.Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.Highly Sensitive Detection of Protein Biomarkers with Organic Electrochemical Transistors.Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers.Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).
P2860
Q24564006-F110816E-AA5F-46C4-B9C3-1E72CA51AAEEQ26777379-03457B05-4C69-4F86-9962-9B6CA0A1EF31Q26824034-654F7ABA-F303-4AE5-8291-892ECDC53EF7Q26852271-A39A8DB1-AAE0-4520-9ED2-68335EBE08EDQ28066912-0A7F6B70-91A8-429A-9C98-3D2D0B6674C4Q30368922-15BBDDE3-BE2D-41DF-86DD-44D478737663Q33703750-685CD5D2-9957-42B5-9CF0-F132352EE4A4Q34117442-73490845-2519-481C-B200-179BC68AA691Q34237245-784F5B5A-5A44-4747-A63A-F96A066C7BF5Q34292436-774B728F-57BF-4F17-BEF3-9875C710E643Q34555445-C1D55E58-C7E0-428D-977C-11A26E01EB39Q34585592-EB1ECA1A-514F-4662-8C89-9B3AC3170CCAQ34657038-C6791FBE-3B41-4C03-90FB-F1CF6E58712DQ35847101-91E2437D-3CD5-4B6A-A5E1-7963F4C066C0Q35920900-A7093A1B-0984-43DF-8E62-27D3057C0DB5Q36118351-2F868414-8CAA-47F3-B711-BC3EFEB46AB5Q36321648-8F313684-221E-4852-B7C4-5CB378971944Q36745621-17CF538D-3561-44C0-8FD8-3E384D4756C5Q37563867-F577D1D9-32A4-463F-A56C-376E893B4061Q37618631-A857265E-0683-4353-ACB0-7F8EFFAB8086Q37620679-F4914492-B811-4CDE-AA20-BDE0A2EDA656Q37623655-2DF78163-1AD2-4D56-ADAD-DA0FACA1A4EFQ37651691-DF4B5E9C-F6F6-4238-985D-03673EFCBC1CQ37690933-E214DB9C-375E-40CE-883C-9481054E952EQ38183147-C2E8B8A6-9A4F-4547-BAD7-509AC1092F6AQ38203040-3AF8DE3B-B483-40F1-904B-E41FB060D475Q38265405-A977A4E0-AB4A-4001-B7DB-636409EC84B6Q38591967-C753F8EF-E785-4025-92E3-2F8C8C7E1B59Q38703928-1C3BD479-86EB-440A-B6E6-F68934B90F43Q38753775-52E77B09-784A-4802-B77D-2CF82DB545AFQ38802991-CEFF29AC-DFEC-418B-B439-42F0CAD4BC1EQ39657160-3500F13E-65B8-4E84-946B-4A74941FB343Q40975840-48506C09-5FDE-45C9-AF79-1C6E62776D07Q41288575-07177BB8-2C7C-47A2-9DC2-7808127FA605Q42613865-8762624B-0095-48AC-A74D-FD49D1F08AF2Q47154567-F409F2F9-8F9C-4192-9D82-2987AB35E14BQ47689680-3EF290F4-6C91-4B20-B7B4-69DD57A633E7Q48113573-A11A8FB4-7ED2-4CE3-884F-82A79EB7F98BQ48196134-A2B28303-BEA7-413C-9981-F02A1B9C2CEAQ48368428-573ECDE2-2E81-4664-977C-A892D1C40C5E
P2860
Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@ast
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@en
type
label
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@ast
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@en
prefLabel
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@ast
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@en
P2093
P2860
P356
P1476
Multiplex targeted proteomic a ...... c cancer biomarker case study.
@en
P2093
Brian P Milless
Philip R Gafken
Randall E Brand
Sarah Hawley
Teresa A Brentnall
Yasuko Tamura
P2860
P304
P356
10.1021/PR201117W
P577
2012-02-08T00:00:00Z